|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1ST TIME HERE?.....CLICK THE FLASHING RED BUTTON ON THE LEFT! | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
October 27, 2005FEDS choose Metabolon for multiple sclerosis study - Metabolon to Identify Disease Biomarkers for CDC Multiple Sclerosis Study
MORE : "There is currently no known cause of MS, but evidence indicates
that it is a complex disease resulting from a combination of genetic susceptibility and environmental factors, such as heavy metals and toxic chemicals. In this study, blood samples from a group of patients diagnosed with MS and exposed to environmental factors will be compared with blood samples taken from a group of healthy subjects exposed to similar conditions. Metabolon scientists will analyze the samples to identify disease biomarkers that indicate a metabolic difference between the two subject groups. Results from this study could potentially lead to more effective diagnostics and treatments for the disease." |